Rift Valley Fever Virus is a mosquito-transmitted virus causing mortality among farm animals. It is one of the 8 pathogens of the World Health Organisation list of 'top-emerging diseases that are likely to cause major epidemics'. The virus is currently circulating on the continent of Africa but is also a risk for other continents including Europe.
Wageningen Bioveterinary Research developed a live-weakened vaccine that is optimally designed for safety and effectiveness. The vaccine will be further developed together with the industry to achieve effective control of Rift Valley Fever.